Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Prognositc Inpact of Tumor-Infiltrating FOXP3 + Regulatory T Cells in DLBCL Treated with R-CHOP

Naoe Goto, MD, PhD, Hisashi Tsurumi, MD, PhD, Yuhei Shibata, MD, Ryoko Mabuchi, MD, Nobuhiko Nakamura, MD, Hiroshi Nakamura, MD, Junichi Kitagawa, MD, Nobuhiro Kanemura, MD, PhD, Takeshi Hara, MD, PhD, Hisataka Moriwaki, Prof.

Blood (2012) 120 (21): 1555.

https://doi.org/10.1182/blood.V120.21.1555.1555

Published: 2012

Journal Articles

The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation

Pedro Farinha, Abdulwahab Al-Tourah, Karamjit Gill, Richard Klasa, Joseph M. Connors, Randy D. Gascoyne

Blood (2010) 115 (2): 289–295.

https://doi.org/10.1182/blood-2009-07-235598

Published: 2010

Journal Articles

Defective Circulating CD25 Regulatory T Cells in Patients with Chronic Immune Thrombocytopenic Purpura.

Jin Yu, MD, Vivek Patel, BS, Susanne Heck, PhD, Jared Levan, BS, Yu Yu, MD, James B. Bussel, MD, Karina Yazdanbakhsh, PhD

Blood (2007) 110 (11): 570.

https://doi.org/10.1182/blood.V110.11.570.570

Published: 2007

Journal Articles

Differences in Regulatory T Cell Function in Alloimmunized Versus Non-Alloimmunized Mice Following Multiple Red Cell Transfusions.

Jin Yu, MD, Susanne Heck, PhD, Karina Yazdanbakhsh, PhD

Blood (2007) 110 (11): 452.

https://doi.org/10.1182/blood.V110.11.452.452

Published: 2007

Journal Articles

A Pilot Phase II Trial of a Synthetic Tumor-Specific Breakpoint Peptide Vaccine in Patients with Chronic Myeloid Leukemia (CML) and Minimal Residual Disease.

Jorge Cortes, MD, James M. Reuben, MD, David Scheinberg, MD, Bang-Ning Lee, PhD, Hui Gao, PhD, Changping Li, MD, Rosemary Mazanet, MD, Dan Jones, MD, Hagop Kantarjian, MD

Blood (2006) 108 (11): 2196.

https://doi.org/10.1182/blood.V108.11.2196.2196

Published: 2006

Journal Articles

FOXP3 Expression in B and T Cell Lymphomas.

Giovanna Roncador, Juan Fernando Garcia, Jose Francisco Garcia, Lorena Maestre, Elena Lucas, Juan Cruz Cigudosa, Lydia Sanchez, Koichi Ohshima, Shigeo Nakamura, Alison Banham, Miguel Angel Piris

Blood (2005) 106 (11): 4503.

https://doi.org/10.1182/blood.V106.11.4503.4503

Published: 2005

Journal Articles

Ex Vivo Expansion of Canine CD4 + CD25 + Regulatory T Cells (T reg ) with Artificial Antigen Presenting Cells (aAPC).

Marina Lesnikova, PhD, Alla Nikitine, MD, Lina Pogosov, Nicola Mason, DVM, Richard A. Nash, MD, George E. Georges, MD

Blood (2005) 106 (11): 3102.

https://doi.org/10.1182/blood.V106.11.3102.3102

Published: 2005

Journal Articles

Generation of CD4 + Regulatory T Cells by Retroviral Transduction of CD4 + CD25 − T Cells Either with the Full-Length or with a Common Exon-2 Negative Variant of Human Foxp3.

Tuna Mutis, MD, PhD, Leo F. Verdonck, MD, PhD, Tineke Aarts-Riemens, Maarten Emmelot

Blood (2005) 106 (11): 3315.

https://doi.org/10.1182/blood.V106.11.3315.3315

Published: 2005

Journal Articles

FOXP1, a Highly Expressed Gene in a Subset of DLBCL, Is Targeted by a Recurrent t(3;14)(p13;q32).

Iwona Wlodarska, PhD, Peter Vandenberghe, MD PhD, Peet Nooien, MD, Anne Hagemeijer, MD PhD, Peter Marynen, PhD, Chris De Wolf-Peeters, MD PhD

Blood (2004) 104 (11): 2891.

https://doi.org/10.1182/blood.V104.11.2891.2891

Published: 2004

Journal Articles

Isolation of Human CD4 + CD25 + T Cells with Regulatory Capacity for Clinical Trials.

Petra Hoffmann, PhD, Ruediger Eder, Biserka Piseshka, Andrea Havasi, Evelyn Orso, MD, Ashraf Dada, MD, Reinhard Andreesen, MD, Ernst Holler, MD, Matthias Edinger, MD

Blood (2004) 104 (11): 2851.

https://doi.org/10.1182/blood.V104.11.2851.2851

Published: 2004

Journal Articles

FoxP3, a Key Molecule in CD4+CD25+ Regulatory T Cells, Express in Adult T Cell Leukemia/Lymphoma Cells and Relates to Clinicopathological Features.

Kennosuke Karube, Koichi Ohshima, Junji Suzumiya, Mine Harada, Masahiro Kikuchi

Blood (2004) 104 (11): 3255.

https://doi.org/10.1182/blood.V104.11.3255.3255

Published: 2004

Journal Articles

Adult T Cell Leukemia/Lymphoma (ATLL) Is a Malignant Counterpart of Regulatory T Cells (Treg).

Tomoko Kohno, MD, Yasuaki Yamada, MD, Norihiko Akamatsu, Shimeru Kamihira, MD, Masao Tomonaga, MD, Tosifumi Matsuyama, MD

Blood (2004) 104 (11): 82.

https://doi.org/10.1182/blood.V104.11.82.82

Published: 2004

Journal Articles

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome

Sharon L. Barrans, James A. L. Fenton, Alison Banham, Roger G. Owen, Andrew S. Jack

Blood (2004) 104 (9): 2933–2935.

https://doi.org/10.1182/blood-2004-03-1209

Published: 2004

NARROW

Prognositc Inpact of Tumor-Infiltrating FOXP3 + Regulatory T Cells in DLBCL Treated with R-CHOP

The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation

Defective Circulating CD25 Regulatory T Cells in Patients with Chronic Immune Thrombocytopenic Purpura.

Differences in Regulatory T Cell Function in Alloimmunized Versus Non-Alloimmunized Mice Following Multiple Red Cell Transfusions.

A Pilot Phase II Trial of a Synthetic Tumor-Specific Breakpoint Peptide Vaccine in Patients with Chronic Myeloid Leukemia (CML) and Minimal Residual Disease.

FOXP3 Expression in B and T Cell Lymphomas.

Ex Vivo Expansion of Canine CD4 + CD25 + Regulatory T Cells (T reg ) with Artificial Antigen Presenting Cells (aAPC).

Generation of CD4 + Regulatory T Cells by Retroviral Transduction of CD4 + CD25 − T Cells Either with the Full-Length or with a Common Exon-2 Negative Variant of Human Foxp3.

FOXP1, a Highly Expressed Gene in a Subset of DLBCL, Is Targeted by a Recurrent t(3;14)(p13;q32).

Isolation of Human CD4 + CD25 + T Cells with Regulatory Capacity for Clinical Trials.

FoxP3, a Key Molecule in CD4+CD25+ Regulatory T Cells, Express in Adult T Cell Leukemia/Lymphoma Cells and Relates to Clinicopathological Features.

Adult T Cell Leukemia/Lymphoma (ATLL) Is a Malignant Counterpart of Regulatory T Cells (Treg).

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only